Amgen, in partnership with Allergan, announced that the U.S. Food and Drug Administration approved its biosimilar for Genentech’s Avastin. The biosimilar Mvasi (bevacizumab-awwb) was approved for a broad swath of cancer indications.
QuintilesIMS’ annual survey of pharmaceutical and device manufacturers was initiated in 2009 – when only a handful of U.S. states required disclosure of certain healthcare practitioner payments. Since then, of course, state, federal and global requirements have continually evolved and expanded. Our latest survey findings, which reflect responses from 112 manufacturers, underscore that while the bar keeps getting higher, manufacturers’ confidence and sophistication are also on the rise.
When it launched in February of 2015, Meerkat looked like it was going to be the hottest social application since Facebook. Two years later, Meerkat’s live-streaming platform is gone, taken down in the fall of 2016 after losing a battle for users with the similar (but Twitter-backed) platform Periscope. But although the players have changed, interest in live streaming has stuck around – and in some cases, grown quickly as users see the possibilities for it and existing social platforms begin adding it to their arsenal of features.
Data is everywhere! And, as marketers, we should leverage data to improve our ability to reach the target audience that is most likely to be receptive to and engaged with our messages. As pharma marketers, we have a unique challenge, as the highly restrictive advertising landscape that we work within presents its own set of obstacles. But we’re up to the challenge; we know that if any industry can benefit from the ability to use data to increase the relevancy and results of digital campaigns, it’s the pharma industry.
Med Ad News’ first edition of the Pharma Leaders of Innovation special feature showcases two CEOs focusing outside the big pharma box and an agency tech leader.
What are key trends in the transparency compliance landscape?
Executives from the 2015 and 2014 Manny Award winners and finalists share their views on a variety of industry-related topics.
Pharma companies have become much more comfortable with the use of mobile in marketing, but with mobile use in general reaching an inflection point, the industry needs to keep pushing past the basics for patients and providers.
For the eighth year, Med Ad News has chosen three Pharmaceutical Marketing Ventures to Watch that could change the way pharmaceutical products are marketed and sold.
Modern physicians are expecting two-way relationships with brands.